<DOC>
	<DOCNO>NCT01795352</DOCNO>
	<brief_summary>This national , multicentre , non-interventional , retrospective study carry oncology setting approximately 15-20 Spanish hospital . At participant hospital , patient recently diagnose advanced EGFR mutate NSCLC ( newly recurrent disease , without previous treatment metastatic disease ) April 2010 December 2011 include study population . Information follow-up patient minimum 12 month diagnosis collect .</brief_summary>
	<brief_title>Retrospective Study NSCLC M+ p</brief_title>
	<detailed_description>Observational retrospective study describe management advance metastatic EGFR mutate non-small cell lung cancer patient Spain</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Histologically cytologically confirm newly locally advanced metastatic NSCLC ( stage IIIB/IV ) Confirmed EGFR mutation validate test Availability medical record Participating blind randomized clinical trial time study period Pregnant woman ( due reflect daily clinical practice )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>EGFR ,</keyword>
	<keyword>lung cancer ,</keyword>
	<keyword>mutate</keyword>
</DOC>